|
Medical device maker Covidien PLC landed 501(k) clearance by the U.S. Food and Drug Administration for its reusable iDrive Ultra powered stapling system.
more
By Emily Greenhalgh |
|
Medical device maker Covidien LLC’s pharmaceutical arm, Mallinckrodt, has entered into a definitive agreement to acquire St. Paul, Minn.-based CNS Therapeutics Inc.
more
By PBN Staff
|
|
Healing fractured bones can be a messy business. Surgeons often employ a toolbox of metal rods, plates, screws and nails to align and stabilize fissured bones. The difficulty of the task worsens with aging or osteoporotic bones.
more
By Robin Respaut
Contributing Writer | 12/17/12 |
|
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration.
more
By Richard Asinof |
|
San Carlos, Calif.-based Natus Medical Inc. has entered into a definitive agreement to acquire the Grass Technologies product group from technology manufacturer Astro-Med Inc. for $18.6 million, the companies announced Monday.
more
By PBN Staff
|
|
Medical device maker Covidien PLC has signed a definitive agreement to acquire Freemont, Calif.-based CV Ingenuity during the first quarter of 2013, the company announced Wednesday.
more
By PBN Staff
|
|
Amgen Inc., one of the world’s largest biotechnology companies, plans to invest $200 million on a new manufacturing facility in Singapore.
more
By Alex Kowalski |
|
The R.I. Economic Development Corporation approved a corporate tax cut Monday night for Alexion Pharmaceuticals under the state’s Jobs Development Act.
more
By Patrick Anderson |
|
The Tech Collective and 41 other state bioscience associations have formed the Coalition of State Bioscience Institutes, a nationally coordinated effort aimed to help ensure U.S. leadership in bioscience innovation.
more
By Emily Greenhalgh |
|
Medical technology maker Covidien PLC reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012.
more
By PBN Staff
|